SLC25A12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.633800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.654800E-01
Normal-vs-Stage2
9.297000E-01
Normal-vs-Stage3
6.555800E-01
Normal-vs-Stage4
9.643400E-01
Stage1-vs-Stage2
2.168800E-01
Stage1-vs-Stage3
1.576830E-01
Stage1-vs-Stage4
3.862000E-01
Stage2-vs-Stage3
4.944600E-01
Stage2-vs-Stage4
8.599400E-01
Stage3-vs-Stage4
7.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.454800E-01
Normal-vs-AfricanAmerican
9.498400E-01
Normal-vs-Asian
9.707800E-01
Caucasian-vs-AfricanAmerican
8.596000E-01
Caucasian-vs-Asian
6.593800E-01
AfricanAmerican-vs-Asian
9.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.002600E-01
Normal-vs-Female
8.164600E-01
Male-vs-Female
6.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.270400E-01
Normal-vs-Age(41-60Yrs)
5.600200E-01
Normal-vs-Age(61-80Yrs)
9.747000E-01
Normal-vs-Age(81-100Yrs)
7.784600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.241800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.386200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.252200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.756000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.285040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.102200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.220200E-01
Normal-vs-Daily Drinker
9.434200E-01
Normal-vs-Weekly Drinker
9.093600E-01
Normal-vs-Occasional Drinker
5.874600E-01
Normal-vs-Social Drinker
5.207600E-01
Non Drinker-vs-Daily Drinker
2.205800E-01
Non Drinker-vs-Weekly Drinker
2.720600E-01
Non Drinker-vs-Occasional Drinker
3.835800E-02
Non Drinker-vs-Social Drinker
5.537800E-02
Daily Drinker-vs-Weekly Drinker
9.050000E-01
Daily Drinker-vs-Occasional Drinker
3.172000E-01
Daily Drinker-vs-Social Drinker
2.066800E-01
Weekly Drinker-vs-Occasional Drinker
4.876000E-01
Weekly Drinker-vs-Social Drinker
2.912000E-01
Occasional Drinker-vs-Social Drinker
5.344000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.472200E-01
Normal-vs-Grade 2
8.193700E-02
Normal-vs-Grade 3
9.005900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.359200E-01
Grade 1-vs-Grade 3
9.206800E-01
Grade 1-vs-Grade 4
2.472200E-01
Grade 2-vs-Grade 3
3.785600E-01
Grade 2-vs-Grade 4
8.193700E-02
Grade 3-vs-Grade 4
9.005900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.756400E-01
Normal-vs-NonDiabetic
9.007800E-01
Diabetic-vs-NonDiabetic
7.706600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.977600E-01
Normal-vs-NoPancreatitis
9.873000E-01
Pancreatitis-vs-NoPancreatitis
1.839550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.506800E-01
Normal-vs-N1
9.576400E-01
N0-vs-N1
2.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.048800E-01
Normal-vs-TP53-NonMutant
6.621400E-01
TP53-Mutant-vs-TP53-NonMutant
5.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
